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Abstract Ricin B chain (RTB) is an N-glycosylated, galactose-
specific lectin. Removal of the two native N-glycosylation sites at 
Asn95 and Asn1 3 5 by site-directed mutagenesis generated a 
recombinant protein devoid of lectin activity. Two novel N-
glycosylation sites were introduced into RTB at Asn42 and 
Asn1 2 3 , either singly or in combination. Microinjection of pre-
RTB transcripts into Xenopus oocytes showed that these novel 
sites became glycosylated in vivo. The single oligosaccharide site 
chain at Asn4 2 restored lectin activity to RTB, whereas 
glycosylation at Asn1 2 3 or simultaneous glycosylation at Asn42 
and Asn1 2 3 failed to do so. 
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1. Introduction 
Ricin is a heterodimeric glycoprotein in which a toxic poly-
peptide (the A chain or RTA) is joined by a disulfide bond to 
a cell-binding polypeptide (the B chain or RTB) [1]. R T B is a 
galactose-specific lectin and both R T A and R T B are glycosy-
lated, each containing two N-glycosylation sites [2]. The X-ray 
crystallographic structure of ricin has shown R T B to be a 
bilobal molecule consisting of two distinct globular domains 
(1 and 2) with identical folding topologies [3], with each do-
main in turn containing three subdomains (a, ß and y, respec-
tively). Each subdomain appears to have been derived from 
the same ancestral galactose-binding peptide [4]. Co-crystalli-
sation of ricin in the presence of lactose demonstrated that 
only subdomains l a and 2y retain significant sugar binding 
activity [5], although a more recent biochemical and muta-
tional analysis of R T B indicates that subdomain Iß may 
also have lectin activity [6]. 
We have produced correctly glycosylated, biologically ac-
tive R T B by microinjecting pre-RTB transcripts into Xenopus 
oocytes [7]. In a mutational analysis of recombinant RTB, we 
found that a non-glycosylated mutan t in which both of the 
Asn residues that normally carry N-linked oligosaccharides 
had been changed to Gin was devoid of lectin activity [8]. 
To further establish the importance of strategically positioned 
N-linked oligosaccharide side chains for lectin activity, we 
have introduced two novel N-glycosylation sites into RTB 
close to the abrogated native sites. Here we report that one 
of these novel introduced glycosylation sites restores lectin 
activity to R TB . 
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2. Materials and methods 
2.1. Mutagenesis 
Mutagenesis of RTB cDNA was performed by standard methods 
using an oligonucleotide-directed in vitro mutagenesis kit (Amersham) 
as instructed by the manufacturer. Mutations were verified by dideoxy 
sequencing. Mutagenic oligonucleotides were synthesised on an Ap-
plied Biosystems Model 380B DNA synthesizer. 
2.2. Synthesis and expression of pre-RTB transcripts 
Pre-RTB cDNAs (encoding wild-type or mutant RTB proceeded by 
the preproricin N-terminal signal sequence) in the vector pSP64T were 
transcribed in vitro in the presence of the capping dinucleotide 7-
Me(5')GpppG(5')OH and SP6 polymerase as described earlier [7]. 
Purified RNA was dissolved in distilled water at a concentration of 
1 mg/ml. Microinjection into Xenopus laevis oocytes (30 nl of RNA 
solution/oocyte) was performed using the Narashige microinjection 
system IM200. Pulse labeling with [35S]methionine and oocyte homog-
enisation were performed as described previously [7]. 
2.3. Binding to immobilised lactose 
The binding of biologically active RTB to lactose was determined 
as described previously [8,9]. Briefly, 1 ml of oocyte homogenate was 
passed down a small column containing 1 ml of lactose immobilised 
onto agarose (Pierce Chemical Co.). Unbound material was washed 
through the column, and bound material was eluted with 50 mM 
lactose. [35S]RTB was recovered from collected fractions by immuno-
precipitation using polyclonal rabbit anti-RTB antibodies, and its 
radioactivity determined by scintillation counting. 
2.4. Binding to immobilised asialofetuin 
Asialofetuin, 300 ul of 100 ug/ml solution in 0.1 M NaHCO,,, was 
dispensed into each well of a 96-well microtitre plate. After storing at 
4°C overnight, unbound asialofetuin was removed and replaced with 
300 ul of blocking solution (PBS, 0.5% (w/v) bovine serum albumin, 
0.05% (v/v) Tween-20). After removing the blocking solution, a 200 ul 
sample of oocyte homogenate was added to each well and the plate 
was incubated at room temperature for 1 h. The sample was removed 
and the wells washed 3 times with PBS. Anti-RTB antibodies that we 
had raised in sheep (200 ul), diluted 1:100 in blocking solution, were 
added to each well. After 1 h at room temperature, the primary anti-
body solution was removed and the wells washed 3 times with PBS. 
Donkey anti-sheep IgG-alkaline phosphatase conjugate (Sigma) (200 
ul), diluted 1:7500 in blocking solution, was added to each well. After 
1 h at room temperature, the solution was removed and the wells 
washed 3 times with PBS. A 5 mg tablet of the alkaline phosphatase 
substrate, p-nitrophenyl phosphate, was dissolved in 5 ml of reaction 
buffer (9.7% (v/v) diethanolamine, 0.02% (w/v) sodium azide, 0.01% 
(w/v) MgCl2-6H20) immediately prior to use. A 200 ul volume of 
substrate solution was added to each well and the colour reaction 
monitored by measuring the absorbance at 405 ran. The reaction 
was stopped by the addition of 100 ul of 3 M NaOH per well. A 
calibration curve was prepared using known amounts of RTB in non-
injected oocyte homogenate. 
2.5. Other methods 
Published procedures were followed for translation of the in vitro 
generated transcripts in a wheat-germ cell-free lysate [10], immuno-
precipitation of RTB from oocyte homogenates [9], SDS-polyacryl-
amide gel electrophoresis and fluorography [11] and enzymic deglyco-
sylation using endo H [12]. 
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Fig. 1. Translation of RTB transcripts in a wheat-germ cell-free sys-
tem in the presence of [35S]methionine. Products were separated by 
SDS-PAGE and visualised by fluorography. Lane M, molecular 
mass markers (68, 45, 30 and 14 kDA as indicated); lane 1, Asn123; 
lane 2, Asn42; lanes 3 and 4, no added transcript; lane 5, RTB; 
lane 6, Asn42/Asn123 ; lane 7, BM5. 
3. Results and discussion 
The two native sugar attachment sites in RTB are Asn95 
and Asn135. The starting point for the present study was an 
RTB mutant (designated BM5) in which these two Asn resi-
dues had been replaced with Gin [8]. An examination of the 
primary sequence and the X-ray crystallographic structure of 
RTB revealed the presence of two Asn residues which are 
physically close to the original N-glycosylation sites in the 
3-dimensional structure: Asn123 (which is close to Asn95) 
and Asn42 (close to Asn135). The position of Asn123 and 
Asn42 in the overall RTB structure also indicated that they 
might be able to accommodate N-linked oligosaccharides 
without significantly disrupting folding of the protein. Ac-
cordingly we used oligonucleotide site-directed mutagenesis 
to convert Asn123 and Asn42 into putative oligosaccharide 
attachment sites by changing Tyr125 and Asp44 respectively 
into Thr. The novel glycosylation sites were introduced into 
RTB either individually or in combination. The RTB mutants 
used in this study are listed in Table 1. 
The RTB sequences were cloned into the transcription vec-
tor pSP64T, and in vitro transcripts were prepared for wild-
type or mutant pre-RTBs using SP6 RNA polymerase [8]. Fig. 
1 shows the products formed when the pre-RTB transcripts 
were translated in a wheat-germ cell-free system. A single 
major product of predicted molecular mass ( ~ 32 kDA) was 
synthesised in each case. Pre-RTB transcripts for proteins 
containing one or two N-glycosylation sites were microin-
jected into Xenopus oocytes and RTB was subsequently recov-
ered from oocyte homogenates by immunoprecipitation using 
rabbit anti-RTB antibodies (Fig. 2). The oocyte products had 
higher apparent molecular masses than the wheat-germ prod-
ucts. Previous work has shown that pre-RTB transcripts in-
jected to Xenopus oocyte generate product that is efficiently 
segregated into the oocyte ER, core-glycosylated, processed to 
Table 1 
RTB N-glycosylation mutants used in the present study (amino acid singl 
Mutations Designation 
None RTB 
N95Q; N135Q BM5 
N95Q; N135Q; Y125T Y125T 
N95Q; N135Q;D44T D44T 
N95Q; N135Q; Y125T; D44T D44T/Y125T 
Fig. 2. Translation of RTB transcripts in Xenopus oocytes. Tran-
scripts were injected into oocytes in the presence of [35S]methionine. 
RTB was recovered from oocyte homogenates by immunoprecipita-
tion, separated by SDS-PAGE, and visualised by fluorography. 
Lane 1, BM5; lane M, molecular mass markers; lane 2, Asn123; 
lane 3, Asn42; lane 4, RTB; lane 5, Asn42/Asn123; lane 6, Asn42. 
remove the N-terminal signal peptide, and folded into the 
biologically active conformation stabilised by four intermolec-
ular disulfide bonds [7]. The oocyte products contained either 
one or two oligosaccharide side chains as expected, and treat-
ment with endo H to remove the attached glycans converted 
all the products to an apparent molecular mass of ~ 30 kDa, 
the predicted size of signal sequence cleaved, non-glycosylated 
RTB (Fig. 3). 
The RTB variants were assayed for lectin activity. Oocyte 
homogenates containing radiolabeled RTBs were passed 
through a small column containing immobilised lactose. After 
washing the column to remove unbound material, bound lec-
tin was eluted with 50 mM galactose and was recovered from 
the collected fractions by immunoprecipitation. As shown in 
Fig. 4, wild-type RTB had lectin activity whereas non-glyco-
sylated BM5 was completely devoid of activity. The RTB 
mutant with a single novel N-glycosylation site at Asn123 
(RTB Y125T) remained inactive, but the novel glycosylation 
site at Asn42 (RTB D44T) restored lectin activity. Mutant 
RTB containing both novel glycosylation sites (RTB D44T/ 
Y125T) was inactive. RTB was the only protein eluted by 
galactose, and no galactose-eluted material was seen when 
radiolabeled homogenate from oocytes mock injected with 
water was applied to the column (data not shown). While 
this simple binding assay provides a convenient demonstration 
of lectin activity, only a small proportion of the immunopre-
cipitated RTB bound to the column ( ~ 1 1 % for wild-type 
RTB and ~ 8 % for the D44T glycosylated mutant). We 
have previously observed similar low levels of binding to im-
mobilised lactose [8,9]. When the unbound RTB which passed 
directly through the column was reapplied to a second col-
umn, further RTB binding occurred which was similar in 
amount to that bound in the first affinity step (data not 
shown). Binding to the glycoprotein asialofetuin, which con-
tains terminal galactose residues, is much more efficient. Asia-
lofetuin is not a useful affinity matrix, however, since bound 
;-letter code) 
Glycosylation sites 
N95/G96/T97;N135/N136/T137 
none 
N123/I124/T125 
N42/T43/T44 
N123/I124/T125; N42/T43/T44 
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Fig. 3. Treatment of recombinant RTB with endo H. RTB tran-
scripts were injected into Xenopus oocytes in the presence of 
[36S]methionine and recovered by immunoprecipitation. Lanes la-
beled + and — represent endo H-treated samples and untreated con-
trols, respectively. Lane M, molecular mass markers; lanes 1 and 2, 
Asn123; lanes 3 and 4, Asn42/Asn123; lanes 5 and 6, RTB; lanes 7 
and 8, Asn42. 
RTB cannot be displaced by solutions of free sugars. Accord-
ingly, the lectin activity of the mutant RTB D44T with a 
glycosylation site at Asn42 was also demonstrated using an 
ELISA which monitored binding to immobilised asialofetuin 
as described in Section 2. The data, which are shown in Fig. 5, 
confirm the results from the immobilised lactose binding assay 
(Fig. 4). From a calibration curve prepared using known 
amounts of RTB in non-injected oocyte homogenate, the 
A405 values shown in Fig. 5 correspond to RTB concentra-
tions of 62.5 ng/ml in homogenates from oocytes expressing 
wild-type RTB, and 50 ng/ml in homogenates from oocytes 
expressing the D44T glycosylation mutant, assuming both 
have equivalent lectin activity. While we have not attempted 
to accurately quantify the lectin activity of functional RTB 
variant, the results are qualitatively very clear: the glycosyla-
tion defective mutant is devoid of lectin activity, as is RTB 
Y125T with an introduced glycosylation site at Asn123, or the 
Fig. 4. Binding of recombinant RTB to immobilised lactose. Homo-
genates from oocytes expressing the appropriate RTB variant were 
applied to columns of immobilised lactose. The columns were 
washed with homogenisation buffer to remove unbound material 
(not shown) and then with buffer containing 50 nM galactose 
(shown). [35S]RTB was recovered by immunoprecipitation from col-
lected fractions (1 ml) and counted. The Fig. shows the RTB eluted 
by galactose as a % of total RTB in the applied sample. 
Fig. 5. Binding of recombinant RTB to immobilised asialofetuin. 
Bound RTB was determined by a sandwich ELISA using sheep 
anti-RTB antibodies followed by donkey anti-sheep antibodies con-
jugated to alkaline phosphatase as described in Section 2. Binding 
was indicated by alkaline phosphatase activity as an absorbance, 
corrected for background, at 405 nm. 
mutant RTB D44T/Y125T doubly glycosylated at Asn42 and 
Asn123, whereas RTB D44T with the single novel glycosyla-
tion site at Asn42 has lectin activity. Further the restored 
lectin activity of RTB D44T is of the same order as that 
determined for wild-type RTB. Clearly the lectin activity re-
stored by the oligosaccharide at Asn42 is compromised when 
Asn123 is simultaneously glycosylated. 
Why is N-glycosylation required for the lectin activity of 
recombinant RTB? We have previously found that non-gly-
cosylated recombinant RTB produced in Xenopus oocytes is 
very unstable and rapidly aggregates on storage [8]. Likewise 
recombinant RTB produced in Escherichia coli, although ini-
tially soluble and biologically active, was unstable and tended 
to aggregate rapidly [13]. Clearly the oligosaccharide side 
chains of RTB appear to stabilise the native conformation. 
This observation, therefore, appears to be another example of 
the well established role for N-linked oligosaccharides in the 
folding and stability of glycoproteins (see [14] for review). The 
X-ray crystallographic structure of RTB shows that the two 
oligosaccharide side chains protrude into solution from close 
to that part of the polypeptide linking domains 1 and 2 [5]. It 
is possible that their strategic location in the RTB molecule 
somehow prevents unproductive interactions between do-
mains 1 and 2 which lead to aggregation when the oligosac-
charides are not present. Domains 1 and 2 of RTB have been 
expressed individually and remain soluble and biologically 
active whether they are [15] or are not [16,17] N-glycosylated. 
Thus it appears that in the absence of the second domain, 
domain 1 or domain 2 on their own do not require the pro-
tection of structural integrity apparently conferred on the bi-
lobal RTB by the oligosaccharide side chains. In a molecule 
containing both domains but with the native N-glycosylation 
sites removed, the novel N-glycosylation site introduced at 
274 
Asn4 2 also appears to introduce a stabilising oligosaccharide 
into mutant R T B which results in the retention of lectin ac-
tivity. 
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